Saint Louis, Missouri-based Centene Corporation (CNC) operates as a healthcare enterprise, providing programs and services to under-insured and uninsured families, commercial organizations, and military families. With a market cap of $18.5 billion, Centene operates through Medicaid, Medicare, Commercial, and Other segments. The healthcare giant is set to release its third-quarter results before the markets open on Wednesday, Oct. 29. Ahead of the event, analysts expect CNC to deliver a non-GAAP loss of $0 ...

10/05/2025Oscar Health shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 80 to 87. 10/05/2025Oscar Health shows improving price performance, earning an upgrade to... Oscar Health Stock Sees RS Rating Jump To 87 S&P 500 health care stocks including Centene (CNC) and Molina Healthcare (MOH) rose early Tuesday after President Trump expressed openness to a deal with Democrats to avert the expiration of enhanced ACA subsidies. While Trump said that Democrats must firs ...

Economic Engagements - Brazil's Finance Minister Fernando Haddad is preparing for potential bilateral discussions at the upcoming G-20 meeting, indicating an active diplomatic agenda [2] - A recent conversation between President Lula and former President Trump was described as "good," suggesting opportunities for further talks with Bessent next week [2] Domestic Economic Indicators - Brazil's FGV Inflation IGP-DI for September showed a month-over-month increase of 0.36%, slightly below the estimated 0.40%, but an acceleration from the previous month's 0.20% [3] AI Economic Impact - San Francisco Federal Reserve President Mary Daly stated that an AI bubble is unlikely to destabilize the financial system, highlighting AI's potential to significantly enhance national productivity [4] - Daly noted no evidence of mass job displacement due to AI, suggesting a gradual impact on the labor market [5] Target Price Revisions - Wells Fargo has raised target prices for several major technology companies, including Microsoft (MSFT) to $675 from $650, and Advanced Micro Devices (AMD) to $275 from $185, reflecting strong confidence in their performance [6] - Other tech upgrades include Meta Platforms (META) with a target price increase to $837 from $811, and Alphabet Inc. (GOOG) to $236 from $187 [7] - In the healthcare sector, UnitedHealth Group (UNH) received a new target price of $400, up from $267, while Humana Inc. (HUM) was raised to $347 from $344, and Elevance Health, Inc. (ELV) to $412 from $330 [8]

Core Insights - Deep-pocketed investors are showing a bullish sentiment towards Centene (NYSE:CNC), indicating potential significant developments ahead [1] - Recent options activity reveals a split sentiment among investors, with 46% bullish and 46% bearish [2] - The target price for Centene is projected to range from $17.5 to $50.0 based on trading activity over the past three months [3] Options Activity - In the last 30 days, there has been unusual options activity for Centene, with a notable volume and open interest in both calls and puts [4][5] - The largest options trades include bullish call options with significant total trade prices, indicating investor confidence [9] Company Overview - Centene is a managed care organization focusing on government-sponsored healthcare plans, serving 22 million medical members as of December 2024, with a majority in Medicaid [10] - The company has a military contract and provides Medicare Part D pharmaceutical plans, diversifying its revenue streams [10] Market Analysis - Recent analyst ratings suggest an average target price of $37.0, with one analyst maintaining an Equal-Weight rating and another a Buy rating with a target of $39 [12][13] - Current trading volume stands at 3,118,567, with the stock price at $38.75, reflecting a slight increase [15]

Centene Corporation (NYSE:CNC) is one of the S&P 500 stocks with a low PE ratio. On September 16, Cantor Fitzgerald assigned a Neutral rating to CNC along with a $38 price target. The firm noted that finalized rates usually match payor proposals but are less than the desired 30%+ increases for 2026, which resulted in a cautious market outlook. Centene, a major player in the Healthcare Providers & Services industry, has a strong financial profile, controlled debt, and a PE ratio of 8.03x. Cantor Fitzgeral ...

Core Points - Centene Corporation will release its 2025 third quarter financial results on October 29, 2025, at 6:00 a.m. ET and will host a conference call at 9:00 a.m. ET to discuss the results [1][2] - The conference call can be accessed via phone or a live audio webcast on Centene's website, with a replay available for 12 months [2] - Centene is a Fortune 500 company focused on providing integrated healthcare services, particularly to under-insured and uninsured individuals, serving over 1 in 15 individuals in the U.S. [3] Company Overview - Centene Corporation is a leading healthcare enterprise committed to helping people live healthier lives, utilizing a local approach with local brands and teams [3] - The company offers affordable and high-quality products, including Medicaid and Medicare services, as well as Health Insurance Marketplace options [3] - Important information about Centene is published on its investor relations website, which is regularly updated with financial and other material information [3]

Core Insights - Whales have shown a bullish stance on Centene, with 46% of trades being bullish and 46% bearish, indicating a balanced sentiment among large investors [1] - The total amount for put trades is $439,754, while call trades amount to $2,196,457, suggesting a stronger interest in calls [1] Options Activity - Over the last three months, whales have targeted a price range for Centene between $25.0 and $55.0 [2] - In the last 30 days, the volume and open interest for Centene's options have been analyzed, providing insights into liquidity and investor interest [3][4] Noteworthy Trades - Significant trades include bullish call options with a total trade price of $303.3K at a strike price of $25.00, and bearish call options with a total trade price of $261.1K at the same strike price [8] - Other notable trades include a bullish put option with a total trade price of $159.9K at a strike price of $37.00 [8] Company Overview - Centene is a managed care organization focusing on government-sponsored healthcare plans, serving 22 million medical members as of December 2024, with a majority in Medicaid [9][10] - The company also provides Medicare Part D pharmaceutical plans and has a military contract [10] Market Analysis - Analysts have provided ratings for Centene, with an average target price of $35.75, and individual targets ranging from $33 to $39 from various analysts [11][12] - The current trading volume for Centene is 5,833,297, with the stock price up by 2.31% to $35.19, indicating potential overbought conditions [14]

Core Insights - Centene Corporation is facing significant challenges due to elevated utilization rates and rising medical costs, similar to pressures affecting the broader healthcare industry [1][4] - Membership losses in Medicaid and Medicare Advantage are eroding Centene's base, leading to a decline in stock price and valuation below industry averages [2][4] Valuation and Performance - Centene's forward P/E ratio is 13.25X, lower than the industry average of 16.16X but above its five-year median of 11.24X [3][6] - The stock has decreased by 43.2% year-to-date, underperforming compared to industry peers and the S&P 500 [4] Financial Metrics - Operating expenses increased by 5.5% in 2023, 5.8% in 2024, and surged by 21.1% in the first half of 2025, driven by rising medical costs [7] - The health benefits ratio (HBR) rose from 87.7% in 2023 to 93% in Q2 2025, indicating reduced profitability [7][8] - Adjusted net margin fell from 2.3% to negative 0.2%, with 2025 EPS guidance revised down to $1.75 from $7.25 [8] Debt and Returns - Centene's long-term debt is $17.6 billion, reflecting a debt-heavy balance sheet due to acquisitions [9] - The trailing 12-month return on invested capital is 6.7%, below the industry average of 9% [9] Market Outlook - The Zacks Consensus Estimate for 2025 earnings is $1.64 per share, a 77.1% decrease year-over-year, with eight downward revisions in the past 60 days [11] - Revenue is expected to grow by 16.9% in 2025, despite the challenges [11] Strengths and Opportunities - Centene's commercial business is expanding, with marketplace memberships increasing by 33.2% in Q2 2025 [15] - Medicare quality scores are stable, with a larger portion of members in four-star plans, which qualify for bonus payments [16] Conclusion - Centene's lower valuation may seem attractive, but underlying issues such as rising medical costs, declining memberships, and heavy debt present significant challenges [17] - While there are some positive indicators, they are insufficient to counterbalance the operational and financial headwinds in the near term [17]

Accessibility StatementSkip Navigation FORT LAUDERDALE. Fla., Sept. 25, 2025 /PRNewswire/ -- Sunshine Health, a company of Centene Corporation (NYSE: CNC), has awarded $106,000 in "Get to Know Us" grants to 50 nonprofit organizations across Florida that deliver vital programs addressing health-related social needs. Each organization received a $2,000 grant to support initiatives that address needs like food insecurity, homelessness and workforce development. Sunshine Health's Marketplace product, Ambetter H ...

Group 1 - Centene Corporation's stock has rebounded significantly, rising 6% on September 24 and nearly 20% over the last month after a period of underperformance [2] - The stock's recent rally suggests it may have been undervalued, attracting investors who were waiting for a pullback [3] - Molina Healthcare appears to be a more attractive investment opportunity compared to Centene, demonstrating stronger revenue growth and profitability [3][6] Group 2 - Molina Healthcare's revenue growth over the last 12 months was 16.1%, while Centene's was 13.0% [6] - Over the last three years, Molina's average revenue growth was 12.8%, surpassing Centene's 8.9% [6] - Molina Healthcare has a last twelve months (LTM) margin of 3.8% and a three-year average margin of 4.2%, outperforming Centene in profitability [6] Group 3 - Centene provides health plan coverage and services to under-insured and uninsured individuals through government programs and commercial healthcare products [4] - Molina Healthcare offers managed healthcare services to low-income families and individuals, catering to 5.2 million members across 18 states [4]